Triomics
PrivateLast Round
Series B
May 27, 2026
Est. Valuation
$1.79M
Total Funding Raised
$51.39M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Triomics is a healthcare technology company that provides an AI-powered platform to automate oncology workflows, including clinical trial matching, patient chart preparation, and data abstraction.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, NLP & Conversational AI, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Triomics Comparables
Compare Triomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Layer Health | 81% | |
| Oncora Medical | 80% | |
| Azra AI | 79% | |
Triomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 27, 2026 | ||||
| Series A | May 9, 2024 | ||||
| Series A | Feb 22, 2023 | ||||
| Accelerator | Mar 1, 2021 | ||||
| Seed | Jan 1, 2021 |
Triomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Venture Highway | Series A |
| Battery Ventures | Series B |
| Y Combinator | Seed, Series A, Accelerator, Series B |
| Oncology Ventures | Series B |
| Nexus Venture Partners | Series A, Series B |
| Lightspeed Venture Partners | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 28, 2026
$22M round led by Battery Ventures.
- Apr 18, 2026
Company grew 10x in one year, processing millions of documents monthly.
Triomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Triomics's valuation, stock price, and market status.